TNL:NYSETravel Leisure Co. Analysis
Data as of 2026-09-01 - not real-time
$68.76
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Travel + Leisure Co. trades at $68.76, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 5.2% over the past 30 days. Relative strength is 35.0 — approaching oversold — and the MACD signal is bearish. Watch $68.57 as support and $79.49 as the nearer resistance level.
Multiples put this in undervalued territory at a P/E of 19.2. Sell-side targets cluster 32.1% above the current quote. Revenue is growing at 4.4% on a 5.8% profit margin. The 3.37% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 32.4%, a beta of 0.89 and a maximum drawdown of 21.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.
Multiples put this in undervalued territory at a P/E of 19.2. Sell-side targets cluster 32.1% above the current quote. Revenue is growing at 4.4% on a 5.8% profit margin. The 3.37% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 32.4%, a beta of 0.89 and a maximum drawdown of 21.1%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.
Top Market Events
Revenue growth supports improved annual guidance Travel + Leisure Co.Travel & Leisure beat revenue expectations by 2% and raised full-year Adjusted EBITDA guidance while posting a slight...Hospitality company Travel + Leisure NYSE:TNL beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 71.40
- MACD momentum is negative
- 30-day price change of -5.2%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 71.40
- Analyst targets imply +32.1% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Analyst targets imply +32.1% versus the current price
- P/E ratio of 19.2
- Dividend yield of 3.37%
Key Metrics & Analysis
Financial Health
Revenue Growth4.40%
Profit Margin5.79%
P/E Ratio19.2
ROA7.36%
P/B Ratio-4.1
Op. Cash Flow$545.0M
Free Cash Flow$556.4M
Technical Analysis
TrendNeutral
RSI35.0
Support$68.57
Resistance$79.49
MA 20$73.78
MA 50$74.69
MA 200$71.40
MACDBearish
VolumeStable
Fear & Greed Index93.71
Valuation
Fair Value$48.34
Target Price$90.85
Upside/Downside32.12%
GradeUndervalued
TypeBlend
Dividend Yield3.37%
Risk Assessment
Beta0.89
Volatility32.43%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.